课题基金 / 基金详情

Obesity-Induced Inflammation and Insulin Resistance by the p62/PKCzeta Signaling

Obesity-Induced Inflammation and Insulin Resistance by the p62/PKCzeta Signaling
p62/PKCzeta 信号传导引起的肥胖引起的炎症和胰岛素抵抗
批准号:
8055418
负责人:
Jorge Moscat
金额:
$41.08万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-01 至 2013-03-31

项目摘要

项目成果

Jorge Moscat的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):肥胖是一个快速增长的公共健康问题。然而,导致身体脂肪过多的潜在机制以及肥胖与其相关病理之间的联系仍然知之甚少。最近的研究揭示了炎症在慢性代谢性疾病(包括肥胖、2型糖尿病和心血管疾病)发病机制中的作用。在这方面,巨噬细胞在这些炎症过程中发挥的作用引起了人们的极大兴趣。已知肥胖增加促进巨噬细胞浸润到脂肪组织,维持局部炎症并引起胰岛素抵抗。最近的研究结果表明,巨噬细胞在响应脂肪细胞分泌的细胞因子如IL-4和IL-13时经历了从促炎(M1表型)到抗炎(M2表型)的极化转换,M1和M2之间的平衡决定了最终的炎症结局及其对胰岛素抵抗的影响。然而,关于负责这些炎症网络的不同信号通路及其在体内的相对重要性的关键问题仍未得到解答。因此,研究肥胖期间激活的炎症通路可能是确定糖尿病新治疗靶点的一种有希望的方法。这项资助申请的重点是p62/PKC6信号复合物,它是由支架蛋白p62及其pb1相互作用激酶PKC6形成的,以及它们在肥胖诱导的炎症和胰岛素抵抗中的潜在作用。这是基于先前的研究结果表明p62基因失活导致晚发性肥胖和胰岛素抵抗,以及相关的全身性高炎症状态。此外,初步数据显示,PKC6-/-小鼠也会发生晚发性肥胖,这表明p62/PKC6复合物在肥胖和肥胖症的控制中起着关键作用。重要的是,高脂肪饮食喂养的PKC6-/-小鼠表现出更高的胰岛素抵抗,脂肪组织中巨噬细胞浸润增加,与等量喂养的WT小鼠相比,尽管体脂含量相同,M1炎症反应增强。这些观察结果导致PKC6是巨噬细胞M2极化开关的调节因子的假设。本提案的总体目标是严格验证p62/PKC6复合物是肥胖期间炎症的关键负调节因子的假设,并确定其在机体和细胞水平上的作用机制。因此,本项目旨在1)确定p62和PKC6在巨噬细胞M2极化中的作用,2)确定巨噬细胞中PKC6和p62在肥胖和肥胖相关炎症中的体内作用。这项工作将增加对肥胖诱导炎症和胰岛素抵抗调节机制的理解,从长远来看,将为开发针对胰岛素抵抗和2型糖尿病的新型、更具体的治疗方法奠定基础。
英文摘要
DESCRIPTION (provided by applicant): Obesity is a rapidly growing public health problem. However, the underlying mechanisms that lead to excess body fat and that link obesity to its associated pathologies remain poorly understood. Recent work has revealed a role for inflammation in the pathogenesis of chronic metabolic diseases including obesity, type 2 diabetes and cardiovascular disease. In this regard, there is a significant interest in the role that macrophages play in these inflammatory processes. It is known that increased adiposity promotes macrophage infiltration into adipose tissue, maintaining local inflammation and causing insulin resistance. Recent results suggest that macrophages undergo a polarization switch from pro-inflammatory (M1 phenotype) to anti-inflammatory (M2 phenotype) in response to adipocyte-secreted cytokines such as IL-4 and IL-13 and the balance between M1 and M2 determines the final inflammatory outcome and its impact on insulin resistance. However, key questions concerning the different signaling pathways responsible for these inflammatory networks and their relative importance in vivo remain unanswered. Therefore, investigation of the inflammatory pathways activated during obesity could be a promising approach to identifying novel therapeutic targets for diabetes. This grant application focuses on the p62/PKC6 signaling complex, which is formed by the scaffold protein p62 and its PB1-interacting kinase PKC6, and their potential role in obesity-induced inflammation and insulin resistance. It is based on previous results demonstrating that the genetic inactivation of p62 leads to late-onset obesity and insulin resistance, and to an associated systemic hyperinflammatory state. Moreover, the preliminary data show that PKC6-/- mice also develop late-onset obesity suggesting a critical role of the p62/PKC6 complex in the control of adiposity and obesity. Importantly, high-fat diet-fed PKC6-/- mice displayed higher insulin resistance, increased macrophage infiltration in adipose tissue, and an enhanced M1 inflammatory response as compared to equally fed WT mice, despite equal body fat content. These observations led to the hypothesis that PKC6 is a regulator of the macrophage M2 polarization switch. The overall objective of this proposal is to rigorously test the hypothesis that the p62/PKC6 complex is a critical negative regulator of inflammation during obesity and to determine its mechanism of action at the organismal and cellular levels. Therefore, this project is designed to 1) determine the role of p62 and PKC6 in M2 polarization of macrophages, and 2) to determine the in vivo role of PKC6 and p62 in macrophages in obesity and obesity-associated inflammation. This work will increase understanding of the mechanisms involved in the regulation of obesity-induce inflammation and insulin resistance, and, in the long term, will lay the groundwork for the development of novel, more specific therapies for insulin resistance and type 2 diabetes. PUBLIC HEALTH RELEVANCE: Chronic inflammation is causally linked to obesity, insulin resistance and type 2 diabetes. Increased adiposity promotes macrophage infiltration into adipose tissue creating a vicious cycle that perpetuates inflammation and causes insulin resistance. This project will determine how a cell signaling complex assembled by p62/Sqstm1 and PKC6 regulates obesity-associated inflammation and insulin resistance in vivo, laying the groundwork for the development of novel, more specific therapies for obesity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cholesterol metabolism in mesenchymal colorectal cancer
Molecular mechanisms driving mesenchymal colorectal cancer
Molecular mechanisms driving mesenchymal colorectal cancer
Interferon regulation by NBR1-driven chaperone-mediated autophagy in stellate cells in liver cancer
国内基金
海外基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制